Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Cancer Care
ASCO President Lists Progress Made in Cancer, Highlighting Current Priorities
By
Wayne Kuznar
Cancer Care
,
Personalized Medicine
August 2017, Vol 8, No 4 | Payers' Perspectives In Oncology: ASCO 2017 Highlights
Chicago, IL—The theme of the 2017 American Society of Clinical Oncology (ASCO) annual meeting was “Making a Difference in Cancer Care With You.” The meeting attracted 38,000 attendees from around the world over 5 days.
Read Article
Big Data in Cancer Care: Limitations of Drug Claims
By
Catherine E. Cooke, PharmD, BCPS
;
F. Randy Vogenberg, PhD, RPh, FASHP
Cancer Care
,
Employers’ Perspective
,
Value Peer-spectives
March 2016, Vol 7, No 2
As one part of an ongoing macrotheme regarding big data, understanding the benefits and limitations of using drug claims in employer-based population health is an important topic for employers in their health plan coverage strategies. Pharmacy claims are a common source of data used to describe the uses of cancer medications by employees and by their covered family members. Despite the availability of these data and a plethora of analyses, however, several limitations must be considered when interpreting drug use data.
Read Article
Predictive Testing Holds More Value to Oncology Stakeholders than Prognostic Testing
By
Wayne Kuznar
Cancer Care
September 2014, Vol 5, No 7
Los Angeles, CA—Predictive testing offers greater value over prognostic testing to most stakeholders in cancer care, because it has a direct impact on disease treatment rather than simply predicting the course of the disease (which is, ironically, the role of prognostic testing), said S. Macey Johnson III, MBA, Vice President, Managed Care and Reimbursement, bioTheranostics, San Diego, CA, at the Fourth Annual Conference of the Association for Value-Based Cancer Care.
Read Article
Getting to Value in Cancer Care: The Time to Have That Conversation Is Now
By
Dana Butler
ASCO 2014 Highlights
,
Cancer Care
,
ASCO
June 2014, Vol 5, No 5
Chicago, IL—The question of value in oncology continues to pose challenges for oncologists and payers alike, as the costs of therapy continue to rise and health plans are wrestling with the need to design insurance coverage that promotes value.
Read Article
Harnessing CMS’s Meaningful Use Criteria to Transform Cancer Care with EMRs
By
Rosemary Frei, MSc
Cancer Care
,
Oncology
,
Personalized Medicine
April 2014, Vol 5, No 3
Washington, DC—A new framework for transforming cancer care by harnessing the meaningful use criteria of the Centers for Medicare & Medicaid Services (CMS) was proposed by a team of researchers at the 2013 American Medical Informatics Association meeting.
Read Article
New Collaborative Advance Care Planning Program for Patients with Cancer Enhances Quality while Mitigating Costs
By
J. Russell Hoverman, MD, PhD
Cancer Care
,
Personalized Medicine
September 2013, Vol 4, No 7
The cancer care landscape is rapidly evolving, in light of promising new therapies, as well as changing reimbursement strategies in response to the healthcare reform.
Read Article
Evolving Practice Standards for Cancer Programs from the Commission on Cancer
By
M. Asa Carter, CTR
Cancer Care
,
Personalized Medicine
May 2012, Vol 3, No 3
What is the most important challenge faced by a person who is diagnosed with cancer today? Opinions will differ, but most patients want to be assured that they will work with a group of multispecialty physicians who will provide recommendations for care that provide the best possible outcomes, that all options for effective treatment will be available to them, that care will be provided in a safe and comfortable hospital or other facility, and that the healthcare staff will care about their problems and concerns with managing treatment, professional issues, and family issues.
Read Article
A New Paradigm of Value-Based Cancer Care: The NCCCP
By
Mark J. Krasna, MD
Cancer Care
,
Economics & Value
,
Value-Based Care
December 2011, Vol 2, No 7
Read Article
Colonoscopy Overused in Medicare Recipients, Adding Unnecessary Expenditures
By
Caroline Helwick
Cancer Care
,
Personalized Medicine
August 2011, Vol 2, No 5
Medicare may be paying for more screening colonos - copies than are warranted for the prevention of colorectal cancer (CRC), according to a new study (Goodwin JS, et al. Arch Intern Med. 2011 May 9 [Epub ahead of print]).
Read Article
HBV Screening Recommended with Chemotherapy, but Not Cost-Effective in Solid Tumors
Cancer Care
,
Personalized Medicine
August 2011, Vol 2, No 5
Most professional guidelines now recommend screening for hepatitis B virus (HBV) infection in essentially all patients receiving chemotherapy, but it is seldom performed and is not cost-effective in patients with solid (nonhematologic) tumors, according to studies presented at ASCO 2011.
Read Article
Page 1 of 2
1
2
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Perioperative Nivolumab Extends Event-Free Survival in Resectable NSCLC
William King
2.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
3.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma